Dexamethasone and COVID-19 in a Developing Country: Appropriate Use? |
Marreros, Diego Martin Moreno
(Division of Internal Medicine, Hospital II Chocope-EsSalud)
Moreno, Maycol Leonardo Aburto (Division of Internal Medicine, Hospital de Alta Complejidad Virgen de la Puerta) Gil, Kattia Gassely Torres (Division of Internal Medicine, Hospital II Chocope-EsSalud) Guzman, Carlos Morera (Division of Internal Medicine, Hospital II Chocope-EsSalud) |
1 | Bahl A, Johnson S, Chen NW. Timing of corticosteroids impacts mortality in hospitalized COVID-19 patients. Int Emerg Med 2021 Feb 5 [Epub]. https://doi.org/10.1007/s11739-021-02655-6. DOI |
2 | Medina ML, Dominguez KC. Self-medication in adults attending the drugstores of the Jesus Nazareno District, Ayacucho 2015. An Fac Med 2016;77:387-92. DOI |
3 | Hermoza-Moquillaza R, Loza-Munarriz C, Rodriguez-Hurtada D, Arellano-Sacramento C, Hermoza-Moquillaza V. Self-medication in district of Lima Metropolitan, Peru. Rev Med Hered 2016;27:15-21. DOI |
4 | Lee HW, Park J, Lee JK, Park TY, Heo EY. The effect of the timing of dexamethasone administration in patients with COVID-19 pneumonia. Tuberc Respir Dis 2021 Mar 29 [Epub]. https://doi.org/10.4046/trd.2021.0309. DOI |
5 | RECOVERY Collaborative Group; Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med 2021;384:693-704. DOI |